News | April 20, 2026
Zorvia opposes adjournment in defamation case against Emcure, Zuventus before Thane Court
The dispute stems from an earlier circular by Zuventus allegedly accusing Zorvia of market sabotage
The dispute stems from an earlier circular by Zuventus allegedly accusing Zorvia of market sabotage
Zero-observation outcomes strengthen global credibility and accelerate CDMO ambitions
The investment case for health technology in India is frequently overstated in one direction and understated in another
The study evaluated asundexian (50 mg), a once-daily oral anticoagulant candidate, versus placebo—both given alongside standard antiplatelet therapy
This development signals a cleanup of Anlon’s borrowing profile and closure of legacy debt facilities
The 12-month alpha-testing phase will bring together ZEISS R&D, three academic collaborators, and three pharmaceutical industry partners
Panacea Biotec receives LoA from CMSS
_256_384.jpg)
Effective recovery at home begins with well-defined care plans that outline treatment protocols, recovery milestones, and monitoring requirements tailored to individual patient needs
A brand from Opella will be part of the official NASA astronaut formulary
Highlights Mirvetuximab-based regimen promise
Subscribe To Our Newsletter & Stay Updated
